Examining the link between hidradenitis suppurativa and heart disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational cohort study aims to investigate the relationship between cardiac biomarkers, advanced echocardiography, and the severity of hidradenitis suppurativa (HS) in a group of 250 patients. The study will assess whether these factors can serve as prognostic markers for heart disease in individuals suffering from HS. Given the shared inflammatory pathways between HS and cardiovascular disease, the research seeks to uncover potential risks and underlying mechanisms linking these conditions. The study will utilize advanced imaging techniques and biomarkers to provide insights into the cardiovascular health of HS patients.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age ≥ 18 years
* Diagnosis of HS

Exclusion Criteria:

* Patients unable to cooperate to the study and/or study examinations
* Patients unable to understand and sign informed consent

Where it's running

• Department of Cardiology, Herlev and Gentofte University Hospital, University of Copenhagen
  Hellerup, Copenhagen, Denmark Recruiting

Study contacts

• Study coordinator: Maria Dons, MD
• Email: maria.flarup.dons.01@regionh.dk
• Phone: +4560604780

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Investigating heart disease risk factors in psoriasis patients

  This study is trying to see if certain heart-related markers can help predict heart disease risk in people with psoriasis.

  Recruiting Herlev and Gentofte Hospital · Hellerup, Copenhagne · NCT04950218

• Using a smartphone device to record 12-lead ECGs for heart attack diagnosis

  This study is testing a smartphone device that records heart activity to see if it can help doctors quickly diagnose heart attacks in adults who come to the emergency room with chest pain.

  Recruiting at 2 sites AliveCor · Rochester, Minnesota and 3 other locations · NCT06271577

• Comparing Aortix Device to Diuretics for Acute Heart Failure

  This study is testing whether the Aortix device can help people with acute heart failure who aren't responding to diuretics feel better compared to standard treatment.

  Recruiting at 33 sites Procyrion · Phoenix, Arizona and 49 other locations · NCT05677100

• LY3971297 in heart failure: safety and tolerability in HF with preserved and reduced ejection fraction

  This study tests how well LY3971297 is tolerated and what side effects occur in people with HFpEF or HFrEF.

  Recruiting Phase 1 Eli Lilly and Company · Detroit, Michigan and 11 other locations · NCT07547540

• Cardiovascular risk in people with Crohn's disease and ulcerative colitis

  This study tests whether people with inflammatory bowel disease have different heart-attack or stroke risk over two years compared with matched controls.

  Recruiting IRCCS Policlinico S. Donato · San Donato Milanese, Milan · NCT07095634

• Optimizing beta-blocker use in older adults with heart failure

  This study is trying to see if a personalized approach to adjusting beta-blocker medication can help older adults with heart failure feel more confident in their treatment and manage their condition better.

  Recruiting Phase 4 Weill Medical College of Cornell University · New York, New York · NCT05585125

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.